UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 21, 2020
Accession Number:
Submission Type:
CIK:
0001553643
Company Name:
RELMADA THERAPEUTICS, INC.
File Number:
333-245054